Zobrazeno 1 - 10
of 40
pro vyhledávání: '"Pratik P Rane"'
Autor:
Gutiérrez Rojas AF; Department of Urology. Fundación Santa Fe de Bogotá, Bogotá, Colombia. Electronic address: andres.gutierrez@fsfb.org.co., Fernández D; Universidad de Los Andes, Bogotá, Colombia., Diaz Ritter C; Department of Urology. Fundación Santa Fe de Bogotá, Bogotá, Colombia.
Publikováno v:
European urology [Eur Urol] 2024 Mar; Vol. 85 (3), pp. e94. Date of Electronic Publication: 2023 Oct 05.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
BMC Public Health, Vol 19, Iss 1, Pp 1-11 (2019)
Abstract Background Atherosclerotic cardiovascular disease (ASCVD) is the leading cause of death in Korea. According to a report of published by Statistics Korea in 2014, cerebrovascular disease and cardiovascular disease were the major/leading cause
Externí odkaz:
https://doaj.org/article/47de6d83d8e44bb1a35183f9cff78113
Publikováno v:
PLoS ONE, Vol 15, Iss 1, p e0228472 (2020)
BACKGROUND:It is important to achieve the low-density lipoprotein cholesterol (LDL-C) goal recommended by clinical guidelines in managing the risk of cardiovascular (CV) events, however, the current management of LDL-C in actual clinical settings is
Externí odkaz:
https://doaj.org/article/aa44eb78faa142d28b2d153fb8b07228
Autor:
Fei-Yuan Hsiao, Wen-Jone Chen, Lian-Yu Lin, Yi Qian, Pratik P. Rane, Kathleen M. Fox, Yao-Chun Wen, Li-Jiuan Shen, Zhongyun Zhao
Publikováno v:
Journal of Evaluation in Clinical Practice. 26:1171-1180
Objectives To assess treatment patterns of statin and/or ezetimibe and possible statin intolerance among patients initiating statin or statin plus ezetimibe and with clinical atherosclerotic cardiovascular disease (ASCVD) or diabetes mellitus (DM) in
Autor:
Gordon G. Liu, Nathan Williams, Jason Shepherd, H. Bailey, Zhongyun Zhao, Yi Qian, Pratik P. Rane
Publikováno v:
Journal of Drug Assessment
Objective: To describe characteristics of patients with dyslipidemia treated in routine care in China overall and stratified by diabetes and atherosclerotic cardiovascular disease (ASCVD). Methods: This study used data from a cross-sectional survey c
Autor:
Yi Qian, Michal Vrablík, Alberico L. Catapano, Olov Wiklund, Mona L. Martin, Pratik P. Rane, Alyson Grove
Publikováno v:
Advances in Therapy
Introduction Statin intolerance (SI) occurs in patients with dyslipidemia treated with statins. Statin-associated symptoms have been reported, but the overall patient experience is poorly understood. No instruments are available to collect this patie
Autor:
Nigel Armstrong, Lisa Stirk, Yi Qian, Pratik P. Rane, Steve Ryder, Kathleen M. Fox, Sohan Deshpande, Ching-Yun Wei, Jos Kleijnen
Publikováno v:
PharmacoEconomics. 37:895-919
IntroductionThere is a lack of comprehensive cost information for cardiovascular events since 2013.ObjectiveA systematic review on the contemporary cost of cardiovascular events was therefore undertaken.MethodsMethods complied with those recommended
Publikováno v:
Research in Social and Administrative Pharmacy. 13:358-363
Background Proton pump inhibitors (PPIs) can lead to several adverse effects among the elderly, particularly when used inappropriately or in contrast to evidence suggested protocols. Objective The aim of this study was to examine the prevalence and p
Publikováno v:
PLoS ONE
PLoS ONE, Vol 15, Iss 1, p e0228472 (2020)
PLoS ONE, Vol 15, Iss 1, p e0228472 (2020)
Background It is important to achieve the low-density lipoprotein cholesterol (LDL-C) goal recommended by clinical guidelines in managing the risk of cardiovascular (CV) events, however, the current management of LDL-C in actual clinical settings is